Drug intelligence / Profile preview

Renotinex

Development stage
Unknown
Lead developer
Polaris Group
Modality
Small Molecules
Administration
Oral
01

Overview

Renotinex is a dietary supplement and herbal complex formulated with a combination of natural terpenes and vitamin E (alpha-tocopherol acetate). It is designed to support the functional state of the urinary system and is primarily used in the management and prevention of urolithiasis (urinary stone disease), particularly in the postoperative period following procedures like contact ureterolithotripsy or extracorporeal shock-wave lithotripsy (ESWL). The active components of Renotinex include alpha-pinene, beta-pinene, camphene, borneol, anethole, fenchone, and cineole. These terpenes exert synergistic effects, including spasmolytic, diuretic, antibacterial, anti-inflammatory, and analgesic activities, which promote the spontaneous passage of renal stones and reduce pain. Vitamin E acts as an antioxidant, protecting renal cell membranes from oxidative stress and lipid peroxidation. Renotinex is manufactured and developed by Polaris.

Brand names
Renotinex
Other names
Ренотинекс

Beyond the preview

Go deeper on Renotinex.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Renotinex.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call